123 related articles for article (PubMed ID: 7896818)
21. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.
Walsh PN
Thromb Haemost; 2001 Jul; 86(1):75-82. PubMed ID: 11487044
[TBL] [Abstract][Full Text] [Related]
22. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
[TBL] [Abstract][Full Text] [Related]
23. RETRACTED: The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane.
Baglia FA; Shrimpton CN; López JA; Walsh PN
J Biol Chem; 2003 Jun; 278(24):21744-50. PubMed ID: 12517745
[TBL] [Abstract][Full Text] [Related]
24. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.
Renné T; Dedio J; Meijers JC; Chung D; Müller-Esterl W
J Biol Chem; 1999 Sep; 274(36):25777-84. PubMed ID: 10464316
[TBL] [Abstract][Full Text] [Related]
25. Binding of coagulation factor XI to washed human platelets.
Greengard JS; Heeb MJ; Ersdal E; Walsh PN; Griffin JH
Biochemistry; 1986 Jul; 25(13):3884-90. PubMed ID: 3017409
[TBL] [Abstract][Full Text] [Related]
26. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
Page JD; You JL; Harris RB; Colman RW
Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
[TBL] [Abstract][Full Text] [Related]
27. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
Hooley E; McEwan PA; Emsley J
J Thromb Haemost; 2007 Dec; 5(12):2461-6. PubMed ID: 17922805
[TBL] [Abstract][Full Text] [Related]
28. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
[TBL] [Abstract][Full Text] [Related]
29. Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86.
Baglia FA; Jameson BA; Walsh PN
J Biol Chem; 1990 Mar; 265(7):4149-54. PubMed ID: 2105959
[TBL] [Abstract][Full Text] [Related]
30. Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.
Sun MF; Zhao M; Gailani D
J Biol Chem; 1999 Dec; 274(51):36373-8. PubMed ID: 10593931
[TBL] [Abstract][Full Text] [Related]
31. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
Meloni FJ; Gustafson EJ; Schmaier AH
Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
[TBL] [Abstract][Full Text] [Related]
32. Factor XI, but not prekallikrein, blocks high molecular weight kininogen binding to human umbilical vein endothelial cells.
Baird TR; Walsh PN
J Biol Chem; 2003 Jun; 278(23):20618-23. PubMed ID: 12663668
[TBL] [Abstract][Full Text] [Related]
33. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
[TBL] [Abstract][Full Text] [Related]
34. Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.
Walsh PN; Sinha D; Koshy A; Seaman FS; Bradford H
Blood; 1986 Jul; 68(1):225-30. PubMed ID: 3487355
[TBL] [Abstract][Full Text] [Related]
35. Identification of a factor IX binding site on the third apple domain of activated factor XI.
Sun Y; Gailani D
J Biol Chem; 1996 Nov; 271(46):29023-8. PubMed ID: 8910554
[TBL] [Abstract][Full Text] [Related]
36. Defective binding of factor XI-N248 to activated human platelets.
Sun MF; Baglia FA; Ho D; Martincic D; Ware RE; Walsh PN; Gailani D
Blood; 2001 Jul; 98(1):125-9. PubMed ID: 11418471
[TBL] [Abstract][Full Text] [Related]
37. Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2.
Renné T; Sugiyama A; Gailani D; Jahnen-Dechent W; Walter U; Müller-Esterl W
Int Immunopharmacol; 2002 Dec; 2(13-14):1867-73. PubMed ID: 12489801
[TBL] [Abstract][Full Text] [Related]
38. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
Tait JF; Fujikawa K
J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
[TBL] [Abstract][Full Text] [Related]
39. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
Thompson RE; Mandle R; Kaplan AP
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
[TBL] [Abstract][Full Text] [Related]
40. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
Mahdi F; Shariat-Madar Z; Schmaier AH
J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
